Used in the synthesis of Raltegravir, an antiretroviral medication for the treatment of HIV infection. It serves as a key intermediate in the manufacturing process, enabling the construction of the core structure with improved efficiency and yield. Its modified fluorine content enhances selectivity during chemical reactions, reducing side products and supporting cleaner production of the active pharmaceutical ingredient. Widely utilized in research and development of HIV integrase inhibitors.